Stanford University
Showing 1-10 of 66 Results
-
Abdullah Qatu, MD
Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Qatu is a board-certified, fellowship-trained pain management specialist at the Stanford Health Care Pain Management Center. He is also a clinical instructor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine, at Stanford University School of Medicine.
He specializes in the diagnosis and management of many different types of pain, including nerve pain, joint pain, cancer pain, low back and neck pain. Dr. Qatu obtained his medical degree from the New York University (NYU) Grossman School of Medicine. He continued on at NYU to complete his residency in anesthesiology after completing an internship in general surgery. He subsequently completed his pain medicine fellowship at Stanford University School of Medicine.
Dr. Qatu believes in utilizing a multimodal approach for pain management. This includes interventional, pharmacological, rehabilitative and psychological strategies. He is well-trained in a wide variety of interventional modalities that include injections, epidurals, nerve blocks, radiofrequency ablations, peripheral nerve stimulation, spinal cord/dorsal root ganglion stimulation and minimally invasive decompression. His research focuses on the clinical use of neuromodulation for various types of pain. In addition, he has investigated whether certain demographic and socioeconomic variables, as well as psychiatric illness, affect the outcomes of various orthopaedic traumas and surgeries. Dr. Qatu has presented his research at conferences throughout the U.S. and in Canada. -
Lei (Stanley) Qi
Associate Professor of Bioengineering
BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is a principal contributor to the development of CRISPR technologies for genome engineering beyond gene editing. His lab created the first nuclease-deactivated Cas9 (dCas9) for targeted gene regulation in cells. His lab has invented a CRISPR toolbox for engineering the epigenome, including CRISPRi and CRISPRa for targeted gene repression and activation, epigenome editing, LiveFISH for real-time DNA/RNA imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a compact CRISPR system for gene therapy, hyperCas12a for multi-gene engineering, and CRISPR antivirals aimed at treating broad RNA viruses.
Dr. Qi obtained B.S. in Physics and Math from Tsinghua University in 2005, and Ph.D. in Bioengineering from the University of California, Berkeley in 2012. He was a Systems Biology Faculty Fellow at UCSF between 2012-2014, and joined Stanford faculty in 2014. His research focuses on mammalian synthetic biology, epigenetic engineering, immune cell engineering, directed evolution, and novel approaches for gene therapy.